In addition, PLCG2 was implicated as a potential tumor suppressor gene in Wilms' tumor with a focal deletion of chromosome 16q22.1q24.3, which resulted in a copy number alteration and downregulation of PLCG2 (145). This evidence concerns the gene PLCG2 and Nephroblastoma.